Guillermo Bahr

Guillermo Bahr

Auto-generated profile, based on publicly available information

Guillermo Bahr

Instituto de Biología Molecular y Celular de Rosario (IBR, CONICET-UNR), Rosario, Argentina

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

16 May 2016 in Nature Chemical Biology
Verified
Journal Article
Open access
PDF file
LGLisandro J González
Lisandro J González
GBGuillermo Bahr
Guillermo Bahr
TNToshiki G Nakashige
Toshiki G Nakashige
ENElizabeth M Nolan
Elizabeth M Nolan
RBRobert A Bonomo
Robert A Bonomo
AVAlejandro Vila
Alejandro Vila
Membrane anchoring protects metallo-β-lactamase NDM-1 from degradation while favoring its secretion into outer-membrane vesicles. This provides carbapenem resistance to bacteria that are sensitive to zinc starvation, which causes degradation of these enzymes. Carbapenems, 'last-resort' β-lactam antibiotics, are inactivated by zinc-dependent metallo-β-lactamases (MBLs). The host innate immune response withholds nutrient metal ions from microbial pathogens by releasing metal-chelating proteins such as calprotectin. We show that metal sequestration is detrimental for the accumulation of MBLs in the bacterial periplasm, because those enzymes are readily degraded in their nonmetallated form. However, the New Delhi metallo-β-lactamase (NDM-1) can persist under conditions of metal depletion. NDM-1 is a lipidated protein that anchors to the outer membrane of Gram-negative bacteria. Membrane anchoring contributes to the unusual stability of NDM-1 and favors secretion of this enzyme in outer-membrane vesicles (OMVs). OMVs containing NDM-1 can protect nearby populations of bacteria from otherwise lethal antibiotic levels, and OMVs from clinical pathogens expressing NDM-1 can carry this MBL and the blaNDM gene. We show that protein export into OMVs can be targeted, providing possibilities of new antibacterial therapeutic strategies.

1 January 2018 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
GBGuillermo Bahr
Guillermo Bahr
LVLuisina Vitor-Horen
Luisina Vitor-Horen
CBChristopher R. Bethel
Christopher R. Bethel
RBRobert A. Bonomo
Robert A. Bonomo
LGLisandro J. González
Lisandro J. González
AVAlejandro Vila
Alejandro Vila
Carbapenem-resistant Enterobacteriaceae (CRE) are rapidly spreading and taking a staggering toll on all health care systems, largely due to the dissemination of genes coding for potent carbapenemases. An important family of carbapenemases are the Zn(II)-dependent β-lactamases, known as metallo-β-lactamases (MBLs). Among them, the New Delhi metallo-β-lactamase (NDM) has experienced the fastest and widest geographical spread. While other clinically important MBLs are soluble periplasmic enzymes, NDMs are lipoproteins anchored to the outer membrane in Gram-negative bacteria. This unique cellular localization endows NDMs with enhanced stability upon the Zn(II) starvation elicited by the immune system response at the sites of infection. Since the first report of NDM-1, new allelic variants (16 in total) have been identified in clinical isolates differing by a limited number of substitutions. Here, we show that these variants have evolved by accumulating mutations that enhance their stability or the Zn(II) binding affinity in vivo , overriding the most common evolutionary pressure acting on catalytic efficiency. We identified the ubiquitous substitution M154L as responsible for improving the Zn(II) binding capabilities of the NDM variants. These results also reveal that Zn(II) deprivation imposes a strict constraint on the evolution of this MBL, overriding the most common pressures acting on catalytic performance, and shed light on possible inhibitory strategies.

1 March 2016 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
PDF file
FPFernando Pasteran
Fernando Pasteran
LGLisandro J. Gonzalez
Lisandro J. Gonzalez
EAEzequiel Albornoz
Ezequiel Albornoz
GBGuillermo Bahr
Guillermo Bahr
AVAlejandro Vila
Alejandro Vila
ACAlejandra Corso
Alejandra Corso
Accurate detection of carbapenemase-producing Gram-negative bacilli is of utmost importance for the control of nosocomial spread and the initiation of appropriate antimicrobial therapy. The modified Hodge test (MHT), a carbapenem inactivation assay, has shown poor sensitivity in detecting the worldwide spread of New Delhi metallo-β-lactamase (NDM). Recent studies demonstrated that NDM is a lipoprotein anchored to the outer membrane in Gram-negative bacteria, unlike all other known carbapenemases. Here we report that membrane anchoring of β-lactamases precludes detection of carbapenemase activity by the MHT. We also show that this limitation can be overcome by the addition of Triton X-100 during the test, which allows detection of NDM. We propose an improved version of the assay, called the Triton Hodge test (THT), which allows detection of membrane-bound carbapenemases with the addition of this nonionic surfactant. This test was challenged with a panel of 185 clinical isolates (145 carrying known carbapenemase-encoding genes and 40 carbapenemase nonproducers). The THT displayed test sensitivity of >90% against NDM-producing clinical isolates, while improving performance against other carbapenemases. Ertapenem provided the highest sensitivity (97 to 100%, depending on the type of carbapenemase), followed by meropenem (92.5 to 100%). Test specificity was not affected by the addition of Triton (87.5% and 92.5% with ertapenem and meropenem, respectively). This simple inexpensive test confers a large improvement to the sensitivity of the MHT for the detection of NDM and other carbapenemases.

3 June 2025 in Chemical Science
Verified
Journal Article
Open access
PDF file
BWBrenda Agustina Warecki
Brenda Agustina Warecki
PTPablo Emiliano Tomatis
Pablo Emiliano Tomatis
MMMaria Mojica
Maria Mojica
CBChristopher R. Bethel
Christopher R. Bethel
MSMagdalena Rodríguez Saravia
Magdalena Rodríguez Saravia
AVAlejandro Vila
Alejandro Vila
The metallo-β-lactamase NDM is able to inactivate the last-generation antibiotic cefiderocol (FDC), in contrast to the related enzymes VIM and IMP. These results provide clues for the therapeutic use of FDC.

2 December 2021 in Current Opinion in Chemical Biology
Verified
Journal Article
Closed access
GBGuillermo Bahr
Guillermo Bahr
LGLisandro J. González
Lisandro J. González
AVAlejandro Vila
Alejandro Vila